0001209191-22-041614.txt : 20220708
0001209191-22-041614.hdr.sgml : 20220708
20220708160617
ACCESSION NUMBER: 0001209191-22-041614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220629
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Al-Wakeel Yasir B.
CENTRAL INDEX KEY: 0001650691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40674
FILM NUMBER: 221074448
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAXCYTE, INC.
CENTRAL INDEX KEY: 0001287098
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 522210438
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-517-5556
MAIL ADDRESS:
STREET 1: 22 FIRSTFIELD ROAD
STREET 2: SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: MAXCYTE INC
DATE OF NAME CHANGE: 20040415
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-29
0
0001287098
MAXCYTE, INC.
MXCT
0001650691
Al-Wakeel Yasir B.
C/O MAXCYTE, INC.
22 FIRSTFIELD ROAD, SUITE 110
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (right to buy)
4.82
2022-06-29
4
A
0
26900
0.00
A
2032-06-28
Common Stock
26900
26900
D
This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date.
/s/ Brian F. Leaf, attorney-in-fact
2022-07-08